Submitted by Anonymous (not verified) on 12 August 2026 - 17:00
Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 32, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 32, Status: Authorised